Sex differences in drug abuse.

What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol (2008) 2.18

Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev (2010) 2.13

Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci (2011) 2.05

Epigenetic inheritance of a cocaine-resistance phenotype. Nat Neurosci (2012) 1.87

Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner. Biol Psychiatry (2012) 1.61

High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains. Genes Brain Behav (2009) 1.60

Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J Neurosci (2011) 1.55

Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individuals. Neuropsychopharmacology (2014) 1.48

Hormonal gain control of a medial preoptic area social reward circuit. Nat Neurosci (2017) 1.44

Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men. J Clin Psychiatry (2016) 1.42

Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol (2008) 1.40

Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology (Berl) (2011) 1.33

The emergence of gonadal hormone influences on dopaminergic function during puberty. Horm Behav (2009) 1.31

Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey. Addiction (2009) 1.29

Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol Sex Differ (2012) 1.27

Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system? Life Sci (2012) 1.27

Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats. Pharmacol Biochem Behav (2009) 1.23

Risk estimates for starting tobacco, alcohol, and other drug use in the United States: male-female differences and the possibility that 'limiting time with friends' is protective. Drug Alcohol Depend (2013) 1.21

Sex differences in the physiology of eating. Am J Physiol Regul Integr Comp Physiol (2013) 1.18

Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Neuropsychol Rev (2009) 1.17

Sex differences in animal models of psychiatric disorders. Br J Pharmacol (2014) 1.15

Cellular and subcellular localization of estrogen and progestin receptor immunoreactivities in the mouse hippocampus. J Comp Neurol (2010) 1.14

HIV, cognition and women. Neuropsychol Rev (2009) 1.11

Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats. Psychopharmacology (Berl) (2008) 1.10

Acquisition of cocaine self-administration in ovariectomized female rats: effect of estradiol dose or chronic estradiol administration. Drug Alcohol Depend (2007) 1.10

Sex differences in novelty- and psychostimulant-induced behaviors of C57BL/6 mice. Psychopharmacology (Berl) (2012) 1.10

Sex Differences in Animal Models: Focus on Addiction. Pharmacol Rev (2016) 1.09

Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways. J Chem Neuroanat (2011) 1.08

Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci (2015) 1.06

"Binge" drinking experience in adolescent mice shows sex differences and elevated ethanol intake in adulthood. Horm Behav (2009) 1.05

Medial prefrontal cortex neuronal activation and synaptic alterations after stress-induced reinstatement of palatable food seeking: a study using c-fos-GFP transgenic female rats. J Neurosci (2012) 1.05

Quantitative analysis of pre- and postsynaptic sex differences in the nucleus accumbens. J Comp Neurol (2010) 1.05

The use of the reinstatement model to study relapse to palatable food seeking during dieting. Neuropharmacology (2013) 1.04

Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology (2010) 1.03

Sexual differentiation of motivation: a novel mechanism? Horm Behav (2009) 1.03

The effects of chronic cigarette smoking on gray matter volume: influence of sex. PLoS One (2014) 1.02

Sex differences in behavioral and neural cross-sensitization and escalated cocaine taking as a result of episodic social defeat stress in rats. Psychopharmacology (Berl) (2012) 1.02

Neural correlates of impulsivity in healthy males and females with family histories of alcoholism. Neuropsychopharmacology (2013) 1.02

Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors. Horm Behav (2009) 1.01

Applying the gender lens to emergency care: from bench to bedside. Acad Emerg Med (2014) 1.01

Responding during signaled availability and nonavailability of iv cocaine and food in rats: age and sex differences. Psychopharmacology (Berl) (2011) 1.00

Sex-specific modulation of gene expression networks in murine hypothalamus. Front Neurosci (2012) 1.00

Sex differences and effects of cocaine on excitatory synapses in the nucleus accumbens. Neuropharmacology (2011) 0.97

Mechanisms of psychostimulant-induced structural plasticity. Cold Spring Harb Perspect Med (2012) 0.97

Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors. J Neuroendocrinol (2009) 0.97

The effects of oral micronized progesterone on smoked cocaine self-administration in women. Horm Behav (2010) 0.97

BNST neurocircuitry in humans. Neuroimage (2014) 0.97

Sex differences in decreased limbic and cortical grey matter volume in cocaine dependence: a voxel-based morphometric study. Addict Biol (2012) 0.96

Estradiol modulates effort-based decision making in female rats. Neuropsychopharmacology (2011) 0.96

Gender differences in acute and chronic pain in the emergency department: results of the 2014 Academic Emergency Medicine consensus conference pain section. Acad Emerg Med (2014) 0.96

Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention? J Child Psychol Psychiatry (2011) 0.95

Effects of a selectively bred novelty-seeking phenotype on the motivation to take cocaine in male and female rats. Biol Sex Differ (2011) 0.95

Sex, ADHD symptoms, and smoking outcomes: an integrative model. Med Hypotheses (2012) 0.95

Baclofen has opposite effects on escalation of cocaine self-administration: increased intake in rats selectively bred for high (HiS) saccharin intake and decreased intake in those selected for low (LoS) saccharin intake. Pharmacol Biochem Behav (2011) 0.95

Viral vector-mediated overexpression of estrogen receptor-alpha in striatum enhances the estradiol-induced motor activity in female rats and estradiol-modulated GABA release. J Neurosci (2009) 0.94

Estradiol reduces dendritic spine density in the ventral striatum of female Syrian hamsters. Brain Struct Funct (2010) 0.94

Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats. Physiol Behav (2011) 0.94

Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective. Front Neurosci (2014) 0.94

Sex differences in impulsive action and impulsive choice. Addict Behav (2013) 0.94

Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake. Psychopharmacology (Berl) (2012) 0.93

Importance of sex differences in impulse control and addictions. Front Psychiatry (2015) 0.92

Ovarian steroids alter mu opioid receptor trafficking in hippocampal parvalbumin GABAergic interneurons. Exp Neurol (2009) 0.92

Emergence of sex differences in the development of substance use and abuse during adolescence. Pharmacol Ther (2015) 0.91

Estrogen regulates responses of dopamine neurons in the ventral tegmental area to cocaine. Psychopharmacology (Berl) (2008) 0.91

The effects of exogenous progesterone on drug craving and stress arousal in cocaine dependence: impact of gender and cue type. Psychoneuroendocrinology (2013) 0.91

Substance abuse may be a risk factor for earlier onset of Huntington disease. J Neurol (2012) 0.91

Cocaine alters dendritic spine density in cortical and subcortical brain regions of the postpartum and virgin female rat. Synapse (2011) 0.90

Persistent palatable food preference in rats with a history of limited and extended access to methamphetamine self-administration. Addict Biol (2015) 0.90

Multigenerational effects of adolescent morphine exposure on dopamine D2 receptor function. Psychopharmacology (Berl) (2013) 0.90

Androgen decreases dopamine neurone survival in rat midbrain. J Neuroendocrinol (2010) 0.90

Sex differences in kappa opioid pharmacology. Life Sci (2010) 0.90

The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals. Adv Pharmacol (2014) 0.90

Estradiol mediates dendritic spine plasticity in the nucleus accumbens core through activation of mGluR5. Brain Struct Funct (2014) 0.89

Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole. Brain Res (2010) 0.89

The influence of sex-linked genetic mechanisms on attention and impulsivity. Biol Psychol (2011) 0.88

Sensitization enhances acquisition of cocaine self-administration in female rats: estradiol further enhances cocaine intake after acquisition. Horm Behav (2009) 0.88

Transient inactivation of the ventral tegmental area selectively disrupts the expression of conditioned place preference for pup- but not cocaine-paired contexts. Behav Neurosci (2009) 0.88

Basal regulation of HPA and dopamine systems is altered differentially in males and females by prenatal alcohol exposure and chronic variable stress. Psychoneuroendocrinology (2013) 0.88

Contributions of neuroimaging to understanding sex differences in cocaine abuse. Exp Clin Psychopharmacol (2011) 0.88

Diminished role of dopamine D1-receptor signaling with the development of an addicted phenotype in rats. Biol Psychiatry (2013) 0.88

Membrane estrogen receptors activate metabotropic glutamate receptors to influence nervous system physiology. Steroids (2008) 0.88

Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Front Integr Neurosci (2013) 0.87

Sex differences in the long-lasting consequences of adolescent ethanol exposure for the rewarding effects of cocaine in mice. Psychopharmacology (Berl) (2015) 0.87

Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens. Brain Res (2008) 0.87

HIV+ men and women show different performance patterns on procedural learning tasks. J Clin Exp Neuropsychol (2010) 0.87

Behavioral mechanisms underlying nicotine reinforcement. Curr Top Behav Neurosci (2015) 0.87

Sex differences in resting state neural networks of nicotine-dependent cigarette smokers. Addict Behav (2014) 0.87

Sex-dependent diversity in ventral tegmental dopaminergic neurons and developmental programing: A molecular, cellular and behavioral analysis. Neuroscience (2014) 0.87

Explaining human recreational use of 'pesticides': The neurotoxin regulation model of substance use vs. the hijack model and implications for age and sex differences in drug consumption. Front Psychiatry (2013) 0.87

Sex differences in the effects of estradiol in the nucleus accumbens and striatum on the response to cocaine: neurochemistry and behavior. Drug Alcohol Depend (2013) 0.86

How reward and emotional stimuli induce different reactions across the menstrual cycle. Soc Personal Psychol Compass (2012) 0.86

Prenatal cocaine exposure increases anxiety, impairs cognitive function and increases dendritic spine density in adult rats: influence of sex. Neuroscience (2010) 0.86

Cocaine- and morphine-induced synaptic plasticity in the nucleus accumbens. Synapse (2010) 0.86

Individual differences in psychostimulant responses of female rats are associated with ovarian hormones and dopamine neuroanatomy. Neuropharmacology (2012) 0.85

Neural mechanisms of reproduction in females as a predisposing factor for drug addiction. Front Neuroendocrinol (2010) 0.85

A research agenda for gender and substance use disorders in the emergency department. Acad Emerg Med (2014) 0.85

Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram. Drug Alcohol Depend (2014) 0.84

Juvenile methylphenidate exposure and factors that influence incentive processing. Dev Neurosci (2009) 0.84

Evaluation of sex differences in cannabinoid dependence. Drug Alcohol Depend (2014) 0.84

Ultrastructural analysis of sex differences in nucleus accumbens synaptic connectivity. Brain Struct Funct (2011) 0.84

Strategies and methods for research on sex differences in brain and behavior. Endocrinology (2004) 5.02

Gender differences in substance use disorders. Psychiatr Clin North Am (1999) 4.12

Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol (1999) 3.74

Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds. Nat Neurosci (2005) 3.29

Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend (2004) 3.09

A model system for study of sex chromosome effects on sexually dimorphic neural and behavioral traits. J Neurosci (2002) 3.09

Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berl) (2002) 2.87

Gonadal steroid induction of structural sex differences in the central nervous system. Annu Rev Neurosci (1984) 2.72

Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science (1996) 2.68

A comparison of male and female cocaine abusers. Arch Gen Psychiatry (1989) 2.48

Sex and estrogen influence drug abuse. Trends Pharmacol Sci (2004) 2.41

A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. J Neurosci (2006) 2.40

Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav (1999) 2.33

Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J Comp Neurol (2001) 2.31

ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol (2002) 2.20

Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol (2003) 2.19

Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol (1999) 2.11

The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berl) (1989) 2.05

Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology (Berl) (1999) 2.04

Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci (1996) 2.04

The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) (2001) 2.02

Sex chromosome genes directly affect brain sexual differentiation. Nat Neurosci (2002) 1.95

A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology (2006) 1.90

Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res (2005) 1.86

Male-female differences in the earliest stages of drug involvement. Addiction (1999) 1.86

Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res (2006) 1.84

XY female mice resulting from a heritable mutation in the primary testis-determining gene, Tdy. Development (1990) 1.83

Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology (2006) 1.83

G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun (2006) 1.79

Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology (2004) 1.79

The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci (1999) 1.76

Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res (2005) 1.71

Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend (1999) 1.64

Sex differences in addict careers. 2. Becoming addicted. Am J Drug Alcohol Abuse (1987) 1.62

Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology (2006) 1.56

Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology (1999) 1.53

Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences. Psychopharmacology (Berl) (2002) 1.53

Gender differences in stress reactivity among cocaine-dependent individuals. Psychopharmacology (Berl) (2005) 1.51

Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci Biobehav Rev (2004) 1.51

Gender differences in cocaine use and treatment response. J Subst Abuse Treat (1993) 1.50

Sex differences in addict careers. 3. Addiction. Am J Drug Alcohol Abuse (1987) 1.50

Sex differences in vulnerability to drug self-administration. Exp Clin Psychopharmacol (2006) 1.48

Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J Neurosci (2003) 1.46

Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) (1999) 1.44

Sex differences in dopamine receptor overproduction and elimination. Neuroreport (1997) 1.43

Male-female differences in transitions from first drug opportunity to first use: searching for subgroup variation by age, race, region, and urban status. J Womens Health Gend Based Med (2001) 1.42

Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure. Drug Alcohol Depend (2002) 1.42

Effects of sex and the estrous cycle on regulation of intravenously self-administered cocaine in rats. Psychopharmacology (Berl) (2000) 1.38

Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release. Synapse (1990) 1.38

Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann N Y Acad Sci (2001) 1.38

Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology (Berl) (2000) 1.37

Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology (2003) 1.36

Effects of progesterone treatment on smoked cocaine response in women. Pharmacol Biochem Behav (2002) 1.34

Estrogen mobilizes a subset of estrogen receptor-alpha-immunoreactive vesicles in inhibitory presynaptic boutons in hippocampal CA1. J Neurosci (2007) 1.33

Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience (2000) 1.33

Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders. J Addict Dis (2003) 1.33

Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res (1982) 1.32

Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology (2001) 1.31

Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats. Pharmacol Biochem Behav (2001) 1.30

Sex differences in the behavioral effects of 24-h/day access to cocaine under a discrete trial procedure. Neuropsychopharmacology (2004) 1.29

Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett (1994) 1.24

Potentiation of cocaine-primed reinstatement of drug seeking in female rats during estrus. Psychopharmacology (Berl) (2005) 1.24

Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci (2003) 1.23

Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology (2001) 1.23

Ethnic and gender differences among opiate addicts. Int J Addict (1985) 1.22

Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J Neurochem (1994) 1.21

Sex differences in negative affective response during nicotine withdrawal. Psychophysiology (2006) 1.20

Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci Lett (1990) 1.19

Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology (2006) 1.18

Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Res (1994) 1.16

Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol Biochem Behav (1991) 1.15

Influence of sex and estrous cyclicity on conditioned cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2005) 1.12

Female gonadal hormones differentially modulate cocaine-induced behavioral sensitization in Fischer, Lewis, and Sprague-Dawley rats. J Pharmacol Exp Ther (1999) 1.11

Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res (1989) 1.10

Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav (2000) 1.09

Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) (1984) 1.07

Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology (2000) 1.05

Sex differences in rats in the development of and recovery from ethanol dependence assessed by changes in seizure susceptibility. Alcohol Clin Exp Res (2001) 1.05

Effect of short- vs. long-term estrogen on reinstatement of cocaine-seeking behavior in female rats. Pharmacol Biochem Behav (2005) 1.03

Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res (1991) 1.02

Roles of estrogen receptor alpha and androgen receptor in the regulation of neuronal nitric oxide synthase. J Comp Neurol (2002) 1.01

Decreased motivation following cocaine self-administration under extended access conditions: effects of sex and ovarian hormones. Neuropsychopharmacology (2005) 0.99

Sex differences in steroid modulation of ethanol withdrawal in male and female rats. J Pharmacol Exp Ther (2006) 0.98

Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci Lett (1997) 0.98

Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro. Brain Res (1981) 0.97

Differential transitions between cocaine use and abstinence for men and women. J Consult Clin Psychol (2007) 0.96

Interactions among ovarian hormones and time of testing on behavioral sensitization and cocaine self-administration. Behav Brain Res (2007) 0.95

Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model. Science (1980) 0.95

Susceptibility to sensitization. I. Sex differences in the enduring effects of chronic D-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines. Behav Brain Res (1988) 0.95

Influence of estrous cycle and estradiol on behavioral sensitization to cocaine in female rats. Drug Alcohol Depend (2002) 0.95

Patterns of drug use among drug misusers in Sweden. Gender differences. Subst Use Misuse (2006) 0.95

Estrogen receptor beta, but not alpha, mediates estrogen's effect on cocaine-induced reinstatement of extinguished cocaine-seeking behavior in ovariectomized female rats. Neuropsychopharmacology (2006) 0.94

Estradiol attenuates the K+-induced increase in extracellular GABA in rat striatum. Synapse (2006) 0.94

The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components. Behav Brain Res (1986) 0.94

Susceptibility to sensitization. II. The influence of gonadal hormones on enduring changes in brain monoamines and behavior produced by the repeated administration of D-amphetamine or restraint stress. Behav Brain Res (1988) 0.92

Estrous cycle influence on individual differences in the response to novelty and cocaine in female rats. Behav Brain Res (2005) 0.92

The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: pharmacological and behavioral evidence. Neuroendocrinology (2003) 0.92

17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur J Pharmacol (1985) 0.91

Acute and repeated intravenous cocaine-induced locomotor activity is altered as a function of sex and gonadectomy. Pharmacol Biochem Behav (2005) 0.90

Sex differences in the effect of amphetamine on immediate early gene expression in the rat dorsal striatum. Brain Res (1996) 0.89

Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell (2010) 6.76

Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. J Biol Chem (2005) 2.68

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol (2013) 2.67

HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data. BMC Bioinformatics (2010) 2.41

Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos (2002) 1.80

The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med (2002) 1.75

Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res (2011) 1.63

Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol Exp Ther (2003) 1.55

Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother (2012) 1.52

Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res (2011) 1.47

Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A (2012) 1.46

Preparing for and responding to public health emergencies in China: a focus group study. J Public Health Policy (2007) 1.40

Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. Am J Med Genet A (2007) 1.37

Enteric disposition and recycling of flavonoids and ginkgo flavonoids. J Altern Complement Med (2003) 1.37

Identification of the position of mono-O-glucuronide of flavones and flavonols by analyzing shift in online UV spectrum (lambdamax) generated from an online diode array detector. J Agric Food Chem (2010) 1.33

Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm (2009) 1.32

Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. PLoS One (2008) 1.29

Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties. Drug Metab Dispos (2006) 1.28

First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci (2011) 1.27

Pharmacokinetics and renal disposition of polymyxin B in an animal model. Antimicrob Agents Chemother (2012) 1.26

Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother Pharmacol (2004) 1.25

Uridine diphosphate glucuronosyltransferase isoform-dependent regiospecificity of glucuronidation of flavonoids. J Agric Food Chem (2011) 1.24

A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studies. J Antimicrob Chemother (2013) 1.23

Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions. Curr Drug Metab (2005) 1.21

MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. J Biol Chem (2012) 1.19

Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein. Drug Metab Dispos (2012) 1.19

Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos (2005) 1.16

Developmental phenotypes and reduced Wnt signaling in mice deficient for pygopus 2. Genesis (2007) 1.15

In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy. Antimicrob Agents Chemother (2014) 1.14

Commentary: bioavailability of flavonoids and polyphenols: call to arms. Mol Pharm (2007) 1.13

Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes. Mol Pharm (2010) 1.13

Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J Pharmacol Exp Ther (2004) 1.13

Ovol1 regulates meiotic pachytene progression during spermatogenesis by repressing Id2 expression. Development (2005) 1.12

The mouse Ovol2 gene is required for cranial neural tube development. Dev Biol (2006) 1.11

Bioavailability challenges associated with development of anti-cancer phenolics. Mini Rev Med Chem (2010) 1.10

Nanoporous carbons through direct carbonization of a zeolitic imidazolate framework for supercapacitor electrodes. Chem Commun (Camb) (2012) 1.09

Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms. Mol Pharm (2007) 1.09

Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA. Mol Pharm (2007) 1.09

Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother (2012) 1.06

Species- and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10. Drug Metab Dispos (2005) 1.05

In vitro potency of various polymyxin B components. Antimicrob Agents Chemother (2011) 1.05

Lateral dimension-dependent antibacterial activity of graphene oxide sheets. Langmuir (2012) 1.05

Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method. J Pharm Biomed Anal (2009) 1.03

Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis. Antimicrob Agents Chemother (2013) 1.03

Natural polyphenol disposition via coupled metabolic pathways. Expert Opin Drug Metab Toxicol (2007) 1.03

Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities. J Pharmacol Exp Ther (2009) 1.02

Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine. AAPS J (2010) 1.01

Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms. Drug Metab Dispos (2011) 1.01

Anisotropic intrinsic lattice thermal conductivity of phosphorene from first principles. Phys Chem Chem Phys (2015) 1.01

Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes. Pharm Res (2004) 1.01

Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice. J Pharm Biomed Anal (2010) 0.99

Direct synthesis of MOF-derived nanoporous carbon with magnetic Co nanoparticles toward efficient water treatment. Small (2014) 0.99

Disposition mechanisms of raloxifene in the human intestinal Caco-2 model. J Pharmacol Exp Ther (2004) 0.99

Facile synthesis of nanoporous carbons with controlled particle sizes by direct carbonization of monodispersed ZIF-8 crystals. Chem Commun (Camb) (2013) 0.98

Regulation of multiple myeloma survival and progression by CD1d. Blood (2008) 0.98

Brief report: Development of a brief scale to assess family support function among Chinese high school students. J Adolesc (2007) 0.98

[An investigation on the prevalence of internet addiction disorder in middle school students of Hunan province]. Zhonghua Liu Xing Bing Xue Za Zhi (2007) 0.98

Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model. J Pharmacol Exp Ther (2010) 0.97

p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development. Oncogene (2003) 0.97

Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice. Antioxid Redox Signal (2011) 0.97

Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes. Pharm Res (2010) 0.96

Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo). Pharm Res (2008) 0.96

(2,2'-Bipyridine-6,6'-dicarboxyl-ato-κN,N',O)(6'-carb-oxy-2,2'-bipyridine-6-carboxyl-ato-κN,N',O)rhodium(III). Acta Crystallogr Sect E Struct Rep Online (2012) 0.96

Interactions among ovarian hormones and time of testing on behavioral sensitization and cocaine self-administration. Behav Brain Res (2007) 0.95

Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine. Pharm Res (2006) 0.94

Viral vector-mediated overexpression of estrogen receptor-alpha in striatum enhances the estradiol-induced motor activity in female rats and estradiol-modulated GABA release. J Neurosci (2009) 0.94

Species and gender differences affect the metabolism of emodin via glucuronidation. AAPS J (2010) 0.94

Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Am J Physiol Gastrointest Liver Physiol (2012) 0.93

Association of human serum apolipoprotein A5 with lipid profiles affected by gender. Clin Chim Acta (2006) 0.93

Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model. Brain Res (2010) 0.92

SCB1, a BURP-domain protein gene, from developing soybean seed coats. Planta (2002) 0.92

The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells. Toxicol Lett (2012) 0.92

Systematic studies of sulfation and glucuronidation of 12 flavonoids in the mouse liver S9 fraction reveal both unique and shared positional preferences. J Agric Food Chem (2012) 0.92

Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis. Curr Drug Metab (2011) 0.91

ATF5 is overexpressed in epithelial ovarian carcinomas and interference with its function increases apoptosis through the downregulation of Bcl-2 in SKOV-3 cells. Int J Gynecol Pathol (2012) 0.91

Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anticancer Agents Med Chem (2012) 0.90

Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis (2013) 0.90

Sex-specific susceptibility to cocaine in rats with a history of prenatal stress. Physiol Behav (2009) 0.89

Validated LC-MS/MS method for the determination of maackiain and its sulfate and glucuronide in blood: application to pharmacokinetic and disposition studies. J Pharm Biomed Anal (2011) 0.89

Disposition of formononetin via enteric recycling: metabolism and excretion in mouse intestinal perfusion and Caco-2 cell models. Mol Pharm (2005) 0.89

A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine J (2008) 0.89

High efficient degradation of dyes with lignin peroxidase coupled with glucose oxidase. J Biotechnol (2006) 0.89

Regioselective glucuronidation of flavonols by six human UGT1A isoforms. Pharm Res (2011) 0.89

Ratio of γ-H2AX level in lymphocytes to that in granulocytes detected using flow cytometry as a potential biodosimeter for radiation exposure. Radiat Environ Biophys (2014) 0.88

Highly variable contents of phenolics in St. John's Wort products affect their transport in the human intestinal Caco-2 cell model: pharmaceutical and biopharmaceutical rationale for product standardization. J Agric Food Chem (2010) 0.88

UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP. Drug Metab Dispos (2011) 0.88

Frequency-tunable anti-Stokes line emission by eigenmodes of a birefringent microstructure fiber. Opt Express (2004) 0.88

Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein. J Altern Complement Med (2008) 0.88

Role of HD2 genes in seed germination and early seedling growth in Arabidopsis. Plant Cell Rep (2011) 0.88

In vitro pharmacodynamics of AZD5206 against Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.88

Transformation of ginsenosides from notoginseng by artificial gastric juice can increase cytotoxicity toward cancer cells. J Agric Food Chem (2014) 0.87

Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy. Cardiovasc Pathol (2012) 0.87

Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese. Metab Syndr Relat Disord (2010) 0.87

A porcine model of intervertebral disc degeneration induced by annular injury characterized with magnetic resonance imaging and histopathological findings. Laboratory investigation. J Neurosurg Spine (2008) 0.87

Highly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug delivery. Chem Commun (Camb) (2012) 0.87

Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora. Drug Metab Dispos (2012) 0.87

Mesoporous metallic cells: design of uniformly sized hollow mesoporous Pt-Ru particles with tunable shell thicknesses. Small (2012) 0.86

Bilateral substrate effect on the thermal conductivity of two-dimensional silicon. Nanoscale (2015) 0.86

Ginsenoside Rb1 directly scavenges hydroxyl radical and hypochlorous acid. Curr Pharm Des (2012) 0.86